BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NeoPharm Inc. 

100 Corporate North, Suite 215

Bannockburn  Illinois  60015  U.S.A.
Phone: 847-295-8678-Ext-115 Fax: 847-295-8854


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Prima Biomed (PRR.AX) And NeoPharm (NEOL) Execute Final Agreement For CVac License 2/21/2014 9:36:42 AM
Prima Biomed (PRR.AX) and NeoPharm (NEOL) Enter Into License for CVac in Israel 11/6/2013 10:40:13 AM
Apricus Biosciences (APRI) and NeoPharm (NEOL) Sign Licensing Agreement for Vitaros(R) in Israel for up to $4.35 Million, Plus Royalties 2/14/2011 9:59:45 AM
Dr. Daniel Von Hoff Joins INSYS Therapeutics/NeoPharm (NEOL) as Chief Development Officer 1/7/2011 9:47:47 AM
Dr. Daniel Von Hoff Joins INSYS Therapeutics/NeoPharm (NEOL) As Chief Development Officer 1/6/2011 11:39:41 AM
NeoPharm (NEOL) Completes Merger with INSYS Therapeutics 11/10/2010 10:42:54 AM
NeoPharm (NEOL) Announces Merger with INSYS Therapeutics 11/1/2010 10:05:18 AM
NeoPharm (NEOL) Announces Second Quarter 2010 Financial Results 8/26/2010 8:27:40 AM
NeoPharm (NEOL) Announces First Quarter 2010 Financial Results and Clinical Trial Update 6/11/2010 9:46:12 AM
NeoPharm (NEOL) Announces FDA Grant of Orphan Drug Designation for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis 5/17/2010 10:00:46 AM
12345678910...